Surgical implant company RTI Surgical™, Inc. has announced the full market launch of its Streamline® OCT System. The system is designed to promote fusion of the occipito-cervico-thoracic spine (or occiput-T3). RTI received U.S. FDA 510(k) clearance for the system in March 2014.
Background
The Streamline OCT System is intended for use in the treatment of spinal stenosis, tumors, degenerative disc disease and spondylolisthesis, among others. It allows a rigid construct to be created from occiput toT3 by offering a broad range of implants.
RTI says the system is the first to offer a high-angle pedicle screw capable of achieving 60 degrees of angulation in any direction, providing greater intraoperative flexibility and options for screw placement. Streamline OCT also offers a unique occipital plate design that reduces the need for extreme rod bends.
Company comments
“The Streamline OCT System is another exciting addition to our spine portfolio,” said Brian K. Hutchison, RTI Surgical president and chief executive officer. “We are proud to have a system that offers a range of implants where surgeons can tailor treatment for their patients and provide a more streamlined surgical experience.”
Dr. Anthony Lapinsky, board-certified orthopedic surgeon at Premier Orthopaedics and Sports Medicine, Bloomingfield, NJ and a Fellow with the American Academy of Orthopaedic Surgeons, is one of the design surgeons for this system.
“The Streamline OCT System, with its unsurpassed modularity, ensures I can manage the variety of clinical challenges I come across in my practice,” said Dr. Lapinsky. “This is due, in large part, to a number of unique implant options, including the highest angle screw on the market.”
Source: RTI Surgical, Inc.
published: April 22, 2014 in: Launches / Withdrawals, Spine